Cytotoxic Drug and HPAPI Manufacturing Market Opportunity Expected to Grow at an Annualized Rate of Approximately 12%, Through 2035, According to Roots Analysis
Root analysis Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those previously considered incurable, the gene therapy pipeline is expanding and the market is expected to experience substantial growth through 2030 London, Nov. 21, 2022 (GLOBE NEWSWIRE) — Root analysis announced the addition of “Cytotoxic Drugs and …